Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
3.
South Med J ; 86(9): 1070-2, 1993 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8367759

RESUMO

C albidus and mucormycosis were cultured simultaneously from the pleural space of a patient with end-stage renal disease receiving long-term hemodialysis. There have been only nine previous reports of infection with C albidus, with only one involving the lung. This organism has never before been isolated from the pleural space, and none of the previously reported cases included a coinfection with mucormycosis. We have reviewed and compared all known cases of infection with C albidus.


Assuntos
Criptococose/complicações , Cryptococcus/isolamento & purificação , Empiema Pleural/complicações , Falência Renal Crônica/complicações , Mucormicose/complicações , Adulto , Idoso , Anfotericina B/uso terapêutico , Criptococose/tratamento farmacológico , Criptococose/fisiopatologia , Empiema Pleural/tratamento farmacológico , Empiema Pleural/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Mucormicose/tratamento farmacológico , Mucormicose/fisiopatologia , Diálise Renal
4.
Am Fam Physician ; 40(3): 223-8, 1989 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2672752

RESUMO

Alpha 1-antitrypsin deficiency is a genetic disorder that may result in premature pulmonary emphysema. Affected persons are deficient in the protective protein, alpha 1-proteinase inhibitor (alpha 1-PI). The diagnosis should be considered in patients with signs of emphysema by age 40 (especially nonsmokers), those with predominantly lower lobe disease and those with a family history of premature emphysema. Recently, human alpha 1-PI has been purified and is available to prevent the development of disabling emphysema in affected individuals. Weekly infusion of the concentrate is effective in raising serum levels and is very safe, with only rare minor adverse effects.


Assuntos
Proteínas Sanguíneas/uso terapêutico , Inibidores de Proteases/uso terapêutico , Enfisema Pulmonar/tratamento farmacológico , Deficiência de alfa 1-Antitripsina , Proteínas Sanguíneas/genética , Proteínas Sanguíneas/farmacologia , Humanos , Inibidores de Proteases/genética , Inibidores de Proteases/farmacologia , Enfisema Pulmonar/diagnóstico , Enfisema Pulmonar/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...